ChemoCentryx
CCXI
#3694
Rank
NZ$6.25 B
Marketcap
NZ$86.96
Share price
0.00%
Change (1 day)
28.92%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): NZ-$2.81

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is NZ-$3.16. In 2021 the company made an earnings per share (EPS) of NZ-$3.16 a decrease over its 2020 EPS that were of NZ-$1.35.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.81-11.07%
2021NZ-$3.16133.33%
2020NZ-$1.35-16.49%
2019NZ-$1.6227.63%
2018NZ-$1.27-305.41%
2017NZ$0.62-142.53%
2016NZ-$1.46-19.44%
2015NZ-$1.81-0%
2014NZ-$1.8113.68%
2013NZ-$1.59-16.67%
2012NZ-$1.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.63-689.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.27-171.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.00-226.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$23.97-858.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.38-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.22-486.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.97-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.30-299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.07-165.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel